Skip to content

Teleflex TFX Americas — Cost of goods sold

Other segment segments

EMEA
$59.53M+72.7%
Asia
$25.4M+51.7%

Similar metrics at other companies

The Vita Coco Company, Inc. logo
COCOAmericas — Cost of goods sold
$87.23M+24.1%
Zimmer Biomet Holdings logo
ZBHAmericas — Cost of Goods Sold
$297.8M+11.3%
MSA
MSAAmericas segment — Cost of products sold
$160.93M+4.4%
Manhattan Associates logo
MANHAmericas — Cost of Goods Sold
$92.95M+12.3%
Apple logo
AAPLAmericas — Cost of Sales
$23.11B+9.6%
Levi Strauss & Co. logo
LEVIAmericas — Cost of goods sold
$376.9M+11.8%

Other financials

Income statement

See full
Revenue$548.3M+32.3%
Gross profit$307.4M+20.4%
Operating income$20.2M-73.4%
Net income-$8.2M-109%
EPS (diluted)-$0.18-109%

Balance sheet

See full
Cash & equivalents$329.6M+16.8%
Total debt$2.8B+38.6%
Total equity$3.1B-24.7%
Total assets$6.8B-5.3%

Cash flow

See full
Operating cash flow$46.7M+68.3%
CapEx$18.8M-22.1%
Free cash flow$27.9M+676%

Valuation

See full
Market cap$5.62B-14.4%
Enterprise value$8.07B-2.0%
P/S2.6×-1.2×

Profitability

See full
Gross margin38.2%-3.0pp
Operating margin3%-11.8pp
Net margin-47.4%-56.2pp
FCF margin7.9%

Returns & leverage

See full
Return on equity-28.1%-31.6pp
Debt / equity0.9×+0.4×
Current ratio2.6×+0.3×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Teleflex’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teleflex's americas — cost of goods sold.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Teleflex's americas — cost of goods sold?
Teleflex (TFX) reported americas — cost of goods sold of $114.16M in Q1 2026.
How has Teleflex's americas — cost of goods sold changed year-over-year?
Teleflex's americas — cost of goods sold increased by 12.2% year-over-year, from $101.75M to $114.16M.
What does americas — cost of goods sold mean?
Includes the direct costs attributable to the production and delivery of medical devices and supplies sold within the Americas segment. It encompasses raw materials, direct labor, and manufacturing overheads required to generate segment revenue.